The effects of recombinant human erythropoietin on perioperative transfusion requirements in patients having a major orthopaedic operation. The American Erythropoietin Study Group.

@article{Faris1996TheEO,
  title={The effects of recombinant human erythropoietin on perioperative transfusion requirements in patients having a major orthopaedic operation. The American Erythropoietin Study Group.},
  author={Philip M. Faris and Merrill A. Ritter and Robert Abels},
  journal={The Journal of bone and joint surgery. American volume},
  year={1996},
  volume={78 1},
  pages={62-72}
}
Two hundred patients who were scheduled for a major elective orthopaedic operation were enrolled in a prospective study and were randomly assigned to one of three treatment groups. Group 1 consisted of sixty patients who received recombinant human erythropoietin, 300 international units per kilogram of body weight per day; Group 2, seventy-one patients who received recombinant human erythropoietin, 100 international units per kilogram of body weight per day; and Group 3, sixty-nine patients who… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 39 extracted citations

Cytokines and Growth Factors in Blood Transfusion

Developments in Hematology and Immunology • 1997
View 4 Excerpts
Highly Influenced

Blood conservation in orthopaedic surgery: the role of epoetin alfa

International Orthopaedics • 2001
View 7 Excerpts
Highly Influenced

Similar Papers

Loading similar papers…